ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 612223 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 612223; 2) Community: the network communities that were significantly associated with the response to NSC 612223; 3) Molecule: the relationships between components within communities and NSC 612223; 4) MDR: the compounds that were significantly associated with the NSC 612223.

NSC Compound Enrichment Correlation
NSC 328130 Null 0.0421163101172308 0.14238848
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0421163101172308 0.30778053
NSC 363812 Tetraplatin 0.0421163101172308 0.29682226
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0421163101172308 0.21357828
NSC 380721 Eremantholide B 0.0421163101172308 0.43591473
NSC 38643 Lenamycin 0.0421163101172308 0.35260732
NSC 39135 Null 0.0421163101172308 0.43381788
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0421163101172308 0.25202436
NSC 645351 [Bis(aminomethyl)diethylsilane]dichloroplatinum (II) 0.0421163101172308 0.47844672
NSC 651081 1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-hydroxy-7-methyl- 0.0421163101172308 0.32530801
Total:96  Current:89    [First] [Prev] [Next] [Last]